Structure–activity relationship studies of curcumin analogues
Authors:
- Dalia AbdelhamidDADalia Abdelhamid
- Pui-Kai LiPLPui-Kai Li
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (7) , 2065-2069
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Role of Curcumin in Cancer TherapyCurrent Problems in Cancer, 2007
- Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of CancerAnnals of the New York Academy of Sciences, 2006
- Activation of NFκB is inhibited by curcumin and related enonesBioorganic & Medicinal Chemistry, 2006
- Chemopreventive and therapeutic effects of curcuminCancer Letters, 2005
- Modulation of arachidonic acid metabolism by curcumin and related -diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenaseCarcinogenesis, 2004
- Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma CellsThe Journal of Immunology, 2003
- Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growthAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complexOncogene, 1999
- AP-1 function and regulationCurrent Opinion in Cell Biology, 1997